Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Acquires Software Platform From Integrated Proteomics Applications

NEW YORK – Bruker said on Wednesday that it has acquired a proteomics software platform from proteomics software firm Integrated Proteomics Applications.

Called the Integrated Proteomics Pipeline (IP2), the platform provides scalable and GPU-based search engine capabilities that Bruker said will enable faster data processing and better use of collision cross section data generated by the ion mobility portion of its timsTOF mass spectrometry system.

Integrated Proteomics Applications is a spinout from the lab of John Yates III, a professor at the Scripps Research Institute. As part of the acquisition, Robin Park, a cofounder of the company, is joining Bruker to head a new San Diego, California-based bioinformatics team that will focus on protein and data science.

"Partnering with the IP2 team and the Yates Lab provides an excellent opportunity to enhance Bruker’s bioinformatics capabilities in support of 4D-Proteomics," Rohan Thakur, Bruker’s executive VP for life science mass spectrometry, said in a statement. "High-throughput proteomics requires unprecedented search engine performance, including the need for low false discovery rates with very large datasets. This will benefit the proteomics research and translational medical community."

"We are very pleased to partner with Bruker in enabling a CCS-aware bioinformatics platform," Yates said. "Innovative software tools are a necessity to address unanswered biological questions with mass spectrometry. The trapped ion mobility functionality and the robustness of the timsTOF Pro offer unique bottom-up proteomics capabilities that can be effectively used to study many diseases."

Financial and other terms of the deal were not disclosed.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.